Pfizer Inc (NYSE: PFE) kicked off on Friday, down -0.50% from the previous trading day, before settling in for the closing price of $25.78. Over the past 52 weeks, PFE has traded in a range of $20.92-$31.54.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -13.25% over the last five years. While this was happening, its average annual earnings per share was recorded -3.65%. With a float of $5.67 billion, this company’s outstanding shares have now reached $5.68 billion.
The firm has a total of 81000 workers. Let’s measure their productivity. In terms of profitability, gross margin is 67.39%, operating margin of 23.65%, and the pretax margin is 11.83%.
Pfizer Inc (PFE) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – General Industry. The insider ownership of Pfizer Inc is 0.18%, while institutional ownership is 67.00%. The most recent insider transaction that took place on May 23 ’25, was worth 1,380,632. Before that another transaction happened on May 05 ’25, when Company’s Former Officer proposed sale 55,000 for $23.87, making the entire transaction worth $1,312,736.
Pfizer Inc (PFE) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -3.65% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.18% during the next five years compared to -13.25% drop over the previous five years of trading.
Pfizer Inc (NYSE: PFE) Trading Performance Indicators
Take a look at Pfizer Inc’s (PFE) current performance indicators. Last quarter, stock had a quick ratio of 0.96. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.33. Likewise, its price to free cash flow for the trailing twelve months is 13.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.38, a number that is poised to hit 0.57 in the next quarter and is forecasted to reach 3.09 in one year’s time.
Technical Analysis of Pfizer Inc (PFE)
Analysing the last 5-days average volume posted by the [Pfizer Inc, PFE], we can find that recorded value of 39.78 million was lower than the volume posted last year of 45.92 million. As of the previous 9 days, the stock’s Stochastic %D was 81.43%.
During the past 100 days, Pfizer Inc’s (PFE) raw stochastic average was set at 74.86%, which indicates a significant decrease from 82.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.43 in the past 14 days, which was lower than the 0.55 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $23.89, while its 200-day Moving Average is $25.65. Now, the first resistance to watch is $25.77. This is followed by the second major resistance level at $25.89. The third major resistance level sits at $26.07. If the price goes on to break the first support level at $25.48, it is likely to go to the next support level at $25.30. Should the price break the second support level, the third support level stands at $25.18.
Pfizer Inc (NYSE: PFE) Key Stats
The company with the Market Capitalisation of 145.83 billion has total of 5,685,366K Shares Outstanding. Its annual sales at the moment are 63,627 M in contrast with the sum of 8,031 M annual income. Company’s last quarter sales were recorded 13,715 M and last quarter income was 2,967 M.
